Loading organizations...
§ Venture Capital · Hangzhou, China
Independent venture capital firm investing in early-stage technology startups, providing funding for AI, healthcare, biotech, SaaS, agri-food.
Beta Capital functions as a venture capital firm, offering strategic funding and hands-on advisory services to promising technology ventures. The firm employs a comprehensive approach that combines financial investment with experienced guidance, aiming to unlock growth potential and navigate complex market landscapes. Their methodology integrates responsible investment principles, ensuring a focus on sustainability and broader stakeholder value in their portfolio companies.
The firm was founded in 2003 by Roberto Branco, who serves as Founder & Managing Partner, and Carlos Rocha, Co-Founder & Partner. Their foundational insight was to establish an independent venture capital entity that would actively partner with innovative companies, extending support beyond mere capital infusion to include strategic counsel and operational assistance, drawing on their team's extensive entrepreneurial background.
Beta Capital primarily serves innovative tech ventures across various sectors, assisting them from their early stages through significant growth milestones. The firm’s long-term vision centers on empowering innovation and contributing to the advancement of its portfolio companies, ultimately driving economic progress while adhering to a commitment to environmental, social, and governance standards.
Betta Capital has 1 tracked investment across 1 company. The latest tracked deal is $27.0M Series C in Drug Farm in May 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 16, 2023 | Drug Farm | $27.0M Series C | YD Capital | Haoyue Capital, Jiashan County State Owned Assets Investment, Wedo Venture Management |